China's Biocytogen gets $78m Series D
Chinese contract research organization (CRO) Biocytogen has raised a RMB543 million ($78 million) Series D round led by China Life Insurance and SDIC Venture Capital, a VC arm of the State Development & Investment Corporation (SDIC).
Existing investors CMB International – an investment arm of China Merchants Bank – Materia Medica Capital, and 3E Bioventures also participated in the funding round, according to a release. All three...
More on Greater China
Latest News
Media SPAC legitimizes MENA for Asia investors
The imminent US listing of a Middle East and North Africa (MENA) media app via a special purpose acquisition company (SPAC) is helping legitimize the region for Asian private equity.
Australia's Quadrant loses growth fund head
Justin Ryan, a managing partner at Quadrant Private Equity and latterly head of the Australian firm’s growth strategy, is stepping back from day-to-day investment activity.
KKR joins $61m round for Japan's Netstars
KKR has contributed JPY4 billion ($37 million) to a JPY6.6 billion funding round for Netstars, a Japanese QR code payment gateway operator. SIG and Lun Partners, a Hong Kong-based global financial technology investor, also took part.
India's PE-backed Pine Labs acquires Malaysia's Fave
Pine Labs, an India payments start-up backed by MasterCard, PayPal, and Sequoia Capital India, has acquired Fave, a Malaysian counterpart also backed by Sequoia India, for $45 million.